SJS Investment Consulting »

Lexicon Pharmaceuticals shares owned by SJS Investment Consulting

Quarter-by-quarter ownership of Lexicon Pharmaceuticals (LXRX) shares owned by SJS Investment Consulting from 13F filings

Historical chart of SJS Investment Consulting investment in Lexicon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lexicon Pharmaceuticals held by SJS Investment Consulting consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexicon Pharmaceuticals by SJS Investment Consulting

Quarter filed Position value Share count Share price at filing
2024-09-30 $628 400 1.57
2024-06-30 $672 400 1.68

More positions owned by SJS Investment Consulting

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Intl Core Equity (DFIC)
Eli Lilly & Co. (LLY)
Dimensional Etf Trust Short Duration F (DFSD)
Hormel Foods Corporation (HRL)
Apple (AAPL)
Vanguard Malvern Fds Core Bd Etf (VCRB)
Dimensional Etf Trust World Ex Us Core (DFAX)
Dimensional Etf Trust Core Fixed Incom (DFCF)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Dimensional Etf Trust Ultrashort Fixed (DUSB)
Dimensional Etf Trust Us Sustainabilty (DFSU)
Vanguard Malvern Fds Strm Infproidx (VTIP)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Global Real Est (DFGR)

View all positions for SJS Investment Consulting

Top funds holding Lexicon Pharmaceuticals

Artal Group
Siren
OrbiMed Advisors
BlackRock
BlackRock
Vanguard Group
Geode Capital Management
NEA Management Company
State Street Corporation
Nantahala Capital Management
Schonfeld Strategic Advisors
Gail Mannix
Charles Schwab Investment Management
Point72 Asset Management
Woodline Partners

View all funds holding Lexicon Pharmaceuticals